Indian Drug Development Firm to Trial Novel COVID-19 Therapy, an Industrial Info Market Brief
PNB Vesper Life Science Private Limited, an Indian Pharma research company claimed its propriety formulation PNB-001-Baladol has shown positive results in all the initial preclinical studies and they are now set to start Phase II human trials to prove efficacy of the novel molecule on 40 moderate patients on oxygen support.
